share_log

新興市場銘柄ダイジェスト:ジェリビンズは大幅に続伸、雨風太陽がストップ高

Emerging markets stock digest: Jelbins significantly extended, Rainfall Sunlight hit the daily limit

Fisco Japan ·  Oct 2 02:27

<150A> JSH 621 -1

Stalemate. It has been announced that a new base for home medical care, 'Visiting Nursing Station Cordia Edo Store,' has been opened in Edogawa-ku, Tokyo. 'Visiting Nursing Station Cordia Edo Store' is a psychiatric home visit examination support service facility. The number of psychiatric patients is increasing year by year, and with the growing demand for home medical care that can be received at home, they are expanding their area to meet the needs.

<206A> PRISMBio 415 -39

Significantly down. Profit-taking sell-off is occurring due to the recoil after a sharp rise the previous day. Some media reported that the technology that can efficiently synthesize compounds that target proteins related to the causes and treatment effects of diseases is being evaluated, stating that, in addition to domestic major players such as Eisai <4523>, mega pharmaceutical companies are also extending their partnership. As a result, there was a rush to buy the stock the previous day. However, it seems that selling is taking the lead today, as it was pushed back at the level before the 25-day moving average line.

<219A> HeartSeed 1626 -17

Decline. It has been announced that the safety review by the High-Dose Group's first case of the phase 1/2 clinical trial (LAPiS trial) of allogeneic iPS cell-derived cardiomyocyte spheres (HS-001) targeting severe heart failure associated with ischemic heart disease has been completed. Following the completion of the review, it has become possible to continue the administration of the high-dose group. The progress after the administration of the first case in the high-dose group has been smooth, aiming to complete the administration of 10 cases of the LAPiS trial by the end of the year.

<4179> Genexst 274 -7

Continued decline. It has been announced that the demonstration experiment of the company's new service 'Discoveriez AI,' which supports the reduction of workloads and business efficiency in customer support utilizing Generative AI (Artificial Intelligence), has started at a major beverage and food business holding company. They are conducting incremental demonstration experiments to enhance the summarization accuracy of telephone response information with customers, automate the categorization of summarization information, and strengthen the information retrieval capabilities internally and externally, evaluating and verifying text generation AI.

LEAR 5616: Rain, Wind, Sun 1675 +300

Trading at the daily limit-up. They have announced the initiation of a new regional marriage support business. By establishing a marriage counseling agency "Chiho Kon!" and expanding the membership of local residents as an opportunity based on the approximately 8,300 nationally registered producers and their connections held by Amefuta Taiyo's direct delivery shopping service 'Pocket Marché', they aim to expand membership. Additionally, they will communicate the appeal of 'regional marriage' through web media and also target urban resident members. With the formation of the Ishiba Cabinet, buying interest continues as part of the local revitalization-related stocks.

SEA 3070: Jelibins 133 +25

Marked increase. Metacity, a company located in Chiyoda-ku, Tokyo, engaged in the development of metaverse, gaming, software, and hardware, announced that it has signed a contract as the exclusive agent for Japan for the blockchain game 'LORD OF DRAGONS' provided by the company. The exclusive agency rights for the Japanese version will be granted for 5 years. In the future, they will actively expand the gaming business and promote related consulting services in anticipation of listing related tokens on cryptocurrency exchanges in Japan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment